Etoricoxib (ETX)

[Edit]

Arcoxia; Coxyveen; Algix; Tauxib; Etorix

Etoricoxib (ETX)
Etoricoxib is a COX-2 selective inhibitor. Like any other COX-2 selective inhibitor ("coxib"), etoricoxib selectively inhibits isoform 2 of the enzyme cyclo-oxygenase (COX-2). This reduces the generation of prostaglandins (PGs) from arachidonic acid. Among the different functions exerted by PGs, their role in the inflammation cascade should be highlighted. COX-2 selective inhibitors showed less marked activity on type 1 cycloxigenase compared to traditional non-steroidal anti-inflammatory drugs (NSAID). This reduced activity is the cause of reduced gastrointestinal side effects, as demonstrated in several large clinical trials performed with different coxibs. Some clinical trials and meta-analysis showed that treatment with some coxibs (in particular rofecoxib) led to increased incidence of adverse cardiovascular events compared to placebo.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Etoricoxib (ETX) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Etoricoxib (ETX) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Etoricoxib (ETX) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Etoricoxib (ETX) CLIA Kit Customized Service Offer
n/a ELISA Kit for Etoricoxib (ETX) ELISA Kit Customized Service Offer